Molecular Profiling of Endometrial Cancer: An Exploratory Study in Aotearoa, New Zealand.
Claire E HenryKhoi PhanElena J OrsmanDiane KenwrightMichelle C ThundersSara K FilochePublished in: Cancers (2021)
Surrogate markers for POLE mutations should be investigated. The validation of POLE variants and CTNNB1 mutations as part of an Aotearoa-based molecular panel is warranted.